Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christos Liaskos

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|September 29, 2015
Breg Cells Are Numerically Decreased and Functionally Impaired in Patients With Systemic SclerosisAthanasios Mavropoulos, Theodora Simopoulou, Areti Varna, et al.
World Journal of Gastroenterology|September 25, 2012
Primary biliary cirrhosis-specific autoantibodies in first degree relatives of Greek primary biliary cirrhosis patientsTheodoros A Zografos, Nikolaos Gatselis, Kalliopi Zachou, et al.
World Journal of Gastroenterology|January 11, 2005
Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: a pilot studyNikolaos K Gatselis, Sarah P Georgiadou, Nikolaos Tassopoulos, et al.
The American Journal of Gastroenterology|January 15, 2008
Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis CTheodoros A Zografos, Christos Liaskos, Eirini I Rigopoulou, et al.
Clinical Immunology (Orlando, Fla.)|February 28, 2006
Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseasesKalliopi Zachou, Christos Liaskos, Eirini Rigopoulou, et al.
Clinical Chemistry and Laboratory Medicine|March 27, 2017
Novel immunoassays for detection of CUZD1 autoantibodies in serum of patients with inflammatory bowel diseasesSofia Farkona, Antoninus Soosaipillai, Panagiota Filippou, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 23, 2009
Prevalence of gastric parietal cell antibodies and intrinsic factor antibodies in primary biliary cirrhosisChristos Liaskos, Gary L Norman, Anargyros Moulas, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 27, 2007
Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosisEirini I Rigopoulou, Dimitrios-Petrou Bogdanos, Christos Liaskos, et al.
Auto- Immunity Highlights|April 21, 2020
A comprehensive analysis of antigen-specific autoimmune liver disease related autoantibodies in patients with multiple sclerosisZisis Tsouris, Christos Liaskos, Efthymios Dardiotis, et al.
Tuberculosis Research and Treatment|December 6, 2012
Tuberculosis is not a risk factor for primary biliary cirrhosis: a review of the literatureDaniel S Smyk, Dimitrios P Bogdanos, Albert Pares, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Arthritis & Rheumatology (Hoboken, N.J.)|September 29, 2015
Breg Cells Are Numerically Decreased and Functionally Impaired in Patients With Systemic SclerosisAthanasios Mavropoulos, Theodora Simopoulou, Areti Varna, et al.
World Journal of Gastroenterology|September 25, 2012
Primary biliary cirrhosis-specific autoantibodies in first degree relatives of Greek primary biliary cirrhosis patientsTheodoros A Zografos, Nikolaos Gatselis, Kalliopi Zachou, et al.
World Journal of Gastroenterology|January 11, 2005
Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: a pilot studyNikolaos K Gatselis, Sarah P Georgiadou, Nikolaos Tassopoulos, et al.
The American Journal of Gastroenterology|January 15, 2008
Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis CTheodoros A Zografos, Christos Liaskos, Eirini I Rigopoulou, et al.
Clinical Immunology (Orlando, Fla.)|February 28, 2006
Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseasesKalliopi Zachou, Christos Liaskos, Eirini Rigopoulou, et al.
Clinical Chemistry and Laboratory Medicine|March 27, 2017
Novel immunoassays for detection of CUZD1 autoantibodies in serum of patients with inflammatory bowel diseasesSofia Farkona, Antoninus Soosaipillai, Panagiota Filippou, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 23, 2009
Prevalence of gastric parietal cell antibodies and intrinsic factor antibodies in primary biliary cirrhosisChristos Liaskos, Gary L Norman, Anargyros Moulas, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 27, 2007
Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosisEirini I Rigopoulou, Dimitrios-Petrou Bogdanos, Christos Liaskos, et al.
Auto- Immunity Highlights|April 21, 2020
A comprehensive analysis of antigen-specific autoimmune liver disease related autoantibodies in patients with multiple sclerosisZisis Tsouris, Christos Liaskos, Efthymios Dardiotis, et al.
Tuberculosis Research and Treatment|December 6, 2012
Tuberculosis is not a risk factor for primary biliary cirrhosis: a review of the literatureDaniel S Smyk, Dimitrios P Bogdanos, Albert Pares, et al.
Pageof 8